CL2016000735A1 - Inhalador de polvo seco que comprende una composición farmacéutica inhalable que comprende propionato de fluticasona, xinafoato de salmeterol y un vehículo de lactosa; uso para tratar asma o epoc. - Google Patents
Inhalador de polvo seco que comprende una composición farmacéutica inhalable que comprende propionato de fluticasona, xinafoato de salmeterol y un vehículo de lactosa; uso para tratar asma o epoc.Info
- Publication number
- CL2016000735A1 CL2016000735A1 CL2016000735A CL2016000735A CL2016000735A1 CL 2016000735 A1 CL2016000735 A1 CL 2016000735A1 CL 2016000735 A CL2016000735 A CL 2016000735A CL 2016000735 A CL2016000735 A CL 2016000735A CL 2016000735 A1 CL2016000735 A1 CL 2016000735A1
- Authority
- CL
- Chile
- Prior art keywords
- dry powder
- powder inhaler
- salmeterol xinafoate
- fluticasone propionate
- epoc
- Prior art date
Links
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 title abstract 4
- 229940112141 dry powder inhaler Drugs 0.000 title abstract 4
- 229960005018 salmeterol xinafoate Drugs 0.000 title abstract 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 title abstract 2
- 229960000289 fluticasone propionate Drugs 0.000 title abstract 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title abstract 2
- 239000008101 lactose Substances 0.000 title abstract 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- 229960004017 salmeterol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
- A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
- A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0076—Mechanical counters having a display or indicator on a drum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
- A61M15/0026—Hinged caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0078—Mechanical counters having a display or indicator on a strip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361887589P | 2013-10-07 | 2013-10-07 | |
| US201361888301P | 2013-10-08 | 2013-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016000735A1 true CL2016000735A1 (es) | 2016-11-11 |
Family
ID=51743574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016000735A CL2016000735A1 (es) | 2013-10-07 | 2016-03-30 | Inhalador de polvo seco que comprende una composición farmacéutica inhalable que comprende propionato de fluticasona, xinafoato de salmeterol y un vehículo de lactosa; uso para tratar asma o epoc. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20160243320A1 (https=) |
| EP (1) | EP3054920B1 (https=) |
| JP (1) | JP6543620B2 (https=) |
| KR (1) | KR102364945B1 (https=) |
| CN (1) | CN105636630B (https=) |
| AU (1) | AU2014332191B2 (https=) |
| BR (1) | BR112016007771B1 (https=) |
| CA (1) | CA2926432A1 (https=) |
| CL (1) | CL2016000735A1 (https=) |
| DK (1) | DK3054920T3 (https=) |
| EA (1) | EA035329B1 (https=) |
| ES (1) | ES2863198T3 (https=) |
| HK (1) | HK1222127A1 (https=) |
| HU (1) | HUE055042T2 (https=) |
| IL (1) | IL244959B (https=) |
| MX (1) | MX374870B (https=) |
| PE (1) | PE20160543A1 (https=) |
| PH (1) | PH12016500619A1 (https=) |
| PL (1) | PL3054920T3 (https=) |
| PT (1) | PT3054920T (https=) |
| TW (1) | TWI673070B (https=) |
| WO (1) | WO2015054124A2 (https=) |
| ZA (1) | ZA201601960B (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9446209B2 (en) | 2011-09-07 | 2016-09-20 | Concentrx Pharmaceuticals, Inc. | Dry powder inhalation device |
| MX374870B (es) * | 2013-10-07 | 2025-03-06 | Teva Branded Pharmaceutical Products R&D Inc | Inhalador de polvo seco. |
| AU356105S (en) * | 2013-11-29 | 2014-06-24 | Norton Waterford Ltd | Respiratory apparatus |
| USD769436S1 (en) * | 2013-11-29 | 2016-10-18 | Norton (Waterford) Limited | Respiratory apparatus |
| USD752734S1 (en) | 2014-03-10 | 2016-03-29 | Civitas Therapeutics, Inc. | Inhaler grip |
| USD755367S1 (en) * | 2014-03-10 | 2016-05-03 | Civitas Therapeutics, Inc. | Indicator for an inhaler |
| USD752204S1 (en) * | 2014-03-10 | 2016-03-22 | Civitas Therapeutics, Inc. | Indicator for an inhaler |
| MA41378A (fr) * | 2015-01-20 | 2017-11-28 | Teva Branded Pharmaceutical Prod R & D Inc | Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol |
| CN107095875B (zh) * | 2016-02-23 | 2022-03-18 | 天津金耀集团有限公司 | 一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物 |
| JP7231410B2 (ja) * | 2016-04-12 | 2023-03-01 | バイオコープ プロダクション エス．アー． | 定量吸入器用アドオン装置、遵守向上システム、及び定量吸入器における使用の遵守向上のための方法 |
| CN106267484A (zh) * | 2016-08-08 | 2017-01-04 | 中山市美捷时包装制品有限公司 | 一种干粉吸入装置的定量供料机构 |
| USD832998S1 (en) * | 2016-10-21 | 2018-11-06 | Norton (Waterford) Limited | Inhaler |
| USD852947S1 (en) * | 2016-10-21 | 2019-07-02 | Norton (Waterford) Limited | Inhaler |
| USD832997S1 (en) * | 2016-10-21 | 2018-11-06 | Norton (Waterford) Limited | Inhaler |
| US11344685B2 (en) | 2016-11-18 | 2022-05-31 | Norton (Waterford) Limited | Drug delivery device with electronics |
| USD853555S1 (en) * | 2017-01-03 | 2019-07-09 | Norton (Waterford) Limited | Inhaler |
| GB201700727D0 (en) * | 2017-01-16 | 2017-03-01 | Teva Pharma | Inhalers and airflow adaptors therefor |
| AU2018244582A1 (en) | 2017-03-28 | 2019-09-19 | Concentrx Pharmaceuticals, Inc. | Devices and methods for delivering dry powder medicaments |
| CN107715264B (zh) * | 2017-10-12 | 2021-01-29 | 上海新黄河制药有限公司 | 一种粉雾剂装置制剂粉末团聚物的分散/解聚装置 |
| CN107737393B (zh) * | 2017-10-12 | 2020-08-28 | 上海新黄河制药有限公司 | 一种用于粉雾剂吸入装置的制剂雾化流道 |
| CN111542308B (zh) | 2017-12-13 | 2024-04-02 | 埃姆弗西斯进出口及分销有限公司 | 干粉吸入器 |
| USD948703S1 (en) * | 2019-07-26 | 2022-04-12 | Lupin Ltd. | Inhaler |
| USD948704S1 (en) * | 2019-07-26 | 2022-04-12 | Lupin Ltd. | Inhaler |
| USD949323S1 (en) * | 2019-07-26 | 2022-04-19 | Lupin Ltd. | Inhaler |
| USD949324S1 (en) * | 2019-07-26 | 2022-04-19 | Lupin Ltd. | Inhaler |
| USD1006214S1 (en) * | 2020-02-14 | 2023-11-28 | Aptar France Sas | Inhaler |
| USD1006213S1 (en) * | 2020-02-14 | 2023-11-28 | Aptar France Sas | Inhaler |
| WO2021219535A1 (en) * | 2020-04-27 | 2021-11-04 | Jt International Sa | Aerosol generation device |
| MX2023001875A (es) | 2020-08-14 | 2023-06-29 | Norton Waterford Ltd | Formulación inhalable de propionato de fluticasona y sulfato de albuterol. |
| GB202012742D0 (en) * | 2020-08-14 | 2020-09-30 | Norton Waterford Ltd | An inhalable medicament |
| KR102767525B1 (ko) | 2022-01-24 | 2025-02-14 | 주식회사 케이티앤지 | 흡입기 |
| KR102782140B1 (ko) | 2022-08-25 | 2025-03-18 | 주식회사 케이티앤지 | 흡입기 |
| KR102864455B1 (ko) | 2022-09-14 | 2025-09-26 | 주식회사 케이티앤지 | 흡입기 |
| KR102783650B1 (ko) | 2022-09-14 | 2025-03-19 | 주식회사 케이티앤지 | 흡입기 |
| KR102885446B1 (ko) | 2022-09-19 | 2025-11-14 | 주식회사 케이티앤지 | 흡입기 |
| KR102917969B1 (ko) | 2022-12-30 | 2026-01-26 | 주식회사 케이티앤지 | 흡입기 |
| CN121816176A (zh) | 2023-07-07 | 2026-04-07 | 诺顿（沃特福特）有限公司 | 一种用于治疗哮喘的丙酸氟替卡松和硫酸沙丁胺醇的吸入制剂 |
| WO2025012114A1 (en) | 2023-07-07 | 2025-01-16 | Norton (Waterford) Limited | An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma |
| EP4487837A1 (en) | 2023-07-07 | 2025-01-08 | Norton (Waterford) Limited | An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma |
| WO2025199032A1 (en) * | 2024-03-18 | 2025-09-25 | Transpire Bio Inc. | Trigger mechanism and powder inhalation device |
| WO2026013023A1 (en) | 2024-07-08 | 2026-01-15 | Norton (Waterford) Limited | A fixed-dose dry powder inhalation formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma |
| EP4678170A1 (en) | 2024-07-08 | 2026-01-14 | Norton (Waterford) Limited | A fixed-dose dry powder inhalation formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| TWI224511B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | De-agglomerator for breath-actuated dry powder inhaler |
| TWI224512B (en) * | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Reservoir pressure system for medicament inhaler |
| GB0124523D0 (en) * | 2001-10-12 | 2001-12-05 | Glaxo Group Ltd | Pharmaceutical combination |
| DE60239639D1 (de) * | 2002-07-31 | 2011-05-12 | Chiesi Farma Spa | Pulverinhalator |
| US20040105821A1 (en) * | 2002-09-30 | 2004-06-03 | Howard Bernstein | Sustained release pharmaceutical formulation for inhalation |
| JP5356367B2 (ja) * | 2007-04-30 | 2013-12-04 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド | 吸入装置 |
| JP2008301847A (ja) * | 2007-06-05 | 2008-12-18 | Canon Inc | 吸入装置及びその駆動方法 |
| EP2197444A1 (en) * | 2007-09-12 | 2010-06-23 | Glaxo Group Limited | Novel combination of therapeutic agents |
| PL3111927T3 (pl) * | 2009-05-29 | 2020-06-29 | Pearl Therapeutics, Inc. | Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy |
| GB0919465D0 (en) * | 2009-11-06 | 2009-12-23 | Norton Healthcare Ltd | Airflow adaptor for a breath-actuated dry powder inhaler |
| EP2571486A4 (en) * | 2010-05-20 | 2013-12-04 | Sun Pharma Advanced Res Co Ltd | DRY POWDER INHALATION COMPOSITION |
| MX374870B (es) * | 2013-10-07 | 2025-03-06 | Teva Branded Pharmaceutical Products R&D Inc | Inhalador de polvo seco. |
| MA41378A (fr) * | 2015-01-20 | 2017-11-28 | Teva Branded Pharmaceutical Prod R & D Inc | Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol |
-
2014
- 2014-10-06 MX MX2016004316A patent/MX374870B/es active IP Right Grant
- 2014-10-06 CN CN201480055333.2A patent/CN105636630B/zh active Active
- 2014-10-06 HK HK16110356.9A patent/HK1222127A1/zh unknown
- 2014-10-06 US US15/027,660 patent/US20160243320A1/en not_active Abandoned
- 2014-10-06 EA EA201690738A patent/EA035329B1/ru not_active IP Right Cessation
- 2014-10-06 CA CA2926432A patent/CA2926432A1/en not_active Withdrawn
- 2014-10-06 BR BR112016007771-7A patent/BR112016007771B1/pt active IP Right Grant
- 2014-10-06 PE PE2016000408A patent/PE20160543A1/es unknown
- 2014-10-06 HU HUE14786419A patent/HUE055042T2/hu unknown
- 2014-10-06 AU AU2014332191A patent/AU2014332191B2/en not_active Ceased
- 2014-10-06 US US14/507,210 patent/US9066957B2/en active Active
- 2014-10-06 JP JP2016520581A patent/JP6543620B2/ja not_active Expired - Fee Related
- 2014-10-06 ES ES14786419T patent/ES2863198T3/es active Active
- 2014-10-06 EP EP14786419.3A patent/EP3054920B1/en active Active
- 2014-10-06 WO PCT/US2014/059285 patent/WO2015054124A2/en not_active Ceased
- 2014-10-06 PT PT147864193T patent/PT3054920T/pt unknown
- 2014-10-06 PL PL14786419T patent/PL3054920T3/pl unknown
- 2014-10-06 DK DK14786419.3T patent/DK3054920T3/da active
- 2014-10-06 KR KR1020167011976A patent/KR102364945B1/ko active Active
- 2014-10-07 TW TW103134890A patent/TWI673070B/zh not_active IP Right Cessation
-
2016
- 2016-03-22 ZA ZA2016/01960A patent/ZA201601960B/en unknown
- 2016-03-30 CL CL2016000735A patent/CL2016000735A1/es unknown
- 2016-04-05 PH PH12016500619A patent/PH12016500619A1/en unknown
- 2016-04-06 IL IL244959A patent/IL244959B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000735A1 (es) | Inhalador de polvo seco que comprende una composición farmacéutica inhalable que comprende propionato de fluticasona, xinafoato de salmeterol y un vehículo de lactosa; uso para tratar asma o epoc. | |
| PE20151655A1 (es) | Aglomerados respirables de particulas de vehiculo porosas y farmaco micronizado | |
| MX2016007182A (es) | Inhalador de polvo seco. | |
| CY1120605T1 (el) | Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης | |
| BR112012026804A2 (pt) | processo para preparar partículas carreadoras de uma formulação em pó seco para inalação, processo para preparar uma formulação em pó seco para inalaçao, mistura de partículas do co-micronizadas, formulação em pó seco, inalador de pó seco e uso de uma mistura de partículas co-micronizadas | |
| BR112016022598A8 (pt) | composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso | |
| PE20150171A1 (es) | Nueva forma de dosificacion y formulacion de abediterol | |
| GT201600050A (es) | Nanopartículas poliméricas terapéuticas y métodos para su elaboración y uso | |
| BR112015027017A2 (pt) | composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas | |
| CL2012003450A1 (es) | Una formulacion en polvo seca inhalable que comprende como ingrediente activo particulas micronizadas de un compuesto antimuscarinico derivado de 1-azonia-biciclo[2.2.2]octano y particulas de un vehiculo; inhalador de polvo seco que la comprende, util para la prevencion y/o el tratamiento de una enfermedad respiratoria tal como asma y epoc. | |
| DOP2019000171A (es) | Formas de administración farmacéutica que contienen inhibidores de canales task-1 y task-3 y su uso para el tratamiento de trastornos respiratorios | |
| BR112014017481A8 (pt) | formulação em pó seco para uso em um inalador de pó seco, inalador de pó seco e uso de uma formulação | |
| HN2011000864A (es) | Particulas inhalables que comprenden tiotropio | |
| CL2013003497A1 (es) | Producto farmacéutico de combinación en forma de polvo seco para administración por medio de un inhalador que comprende una sal de umeclidinio de un grupo definido y 100 mcg/dosis de furoato de fluticasona, sin otros activos adicionales; uso para el tratamiento de enfermedades inflamatorias o del aparato respiratorio. | |
| DOP2019000172A (es) | Formas de administración farmacéutica que contienen inhibidores de canales task-1 y task-3 y su uso para el tratamiento de trastornos respiratorios | |
| HK1217092A1 (zh) | 治疗性化合物及其用途 | |
| PH12014501545A1 (en) | Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof | |
| MX2016007181A (es) | Medicamentos inhalables. | |
| CL2014003211A1 (es) | Composicion farmaceutica para inhalacion que comprende aclidinio, con lactosa, que proporciona una dosis de 322 ug de base libre y aprox 140 ug de bromuro de aclidinio; un metodo para tratar una afeccion respiratoria seleccionada de asma y epoc; uso de la composicion; y un dispositivo inhalador de polvo seco calibrado que la comprende | |
| MX2015014338A (es) | Composicion farmaceutica que continen budesonida y formoterol. | |
| CO2017004512A2 (es) | Composición farmacéutica que contiene budesonida y formoterol | |
| MX2019001701A (es) | Composicion farmaceutica de dosis fija que comprende mometasona y azelastina. | |
| TR200909793A2 (tr) | Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu. | |
| AR098868A1 (es) | Composición farmacéutica en polvo seco para inhalación | |
| TN2013000015A1 (en) | Dry powder formulation comprising a phosphodiesterase inhibitor |